About Clinical Trial Results

About CTR
CTR Format

Motivated by the premise that every trial, regardless of outcome, can have a benefit to the research community, Clinical Trial Results (CTR) from The Oncologist promotes the mission of sharing results and speeding discoveries.

Despite the U.S. federal mandate to report findings of certain clinical trials, the outcomes of many still go unreported. When results are published, their publication lags behind the trial completion by a median of 21 months.* This results in a great loss of valuable information, redundant control groups, and waste of other resources.

In the spirit of cooperation and transparency, CTR offers a powerful solution with an easy online format to encourage the publication of results not otherwise reported. Currently accepting submissions for phase I and phase II trails, CTR facilitates fast-track dissemination of results through a brief Author Summary in print, with an online component offering more extensive clinical findings, pharmacokinetics, adverse event reporting, and full-length discussion.

Designed specifically for the submission of clinical trials, CTR's technical functionalities include the ability to create waterfall plots, adverse event tables, and Kaplan-Meier curves from the investigators' data. To ensure that results are easily discoverable, CTR is fully indexed in MEDLINE/PubMed.

*Ross, JS, Tse T, Zarin DA et al. Publication of NIH funded trials registered in ClinicalTrials.gov: cross sectional analysis. BMJ 2012;344:d7292.


Read the Frequently Asked Questions and Submission Steps here: http://authors.theoncologist.com/images/CTRFAQs.pdf


View the entire collection of published CTRs here: http://theoncologist.alphamedpress.org/site/misc/PublishedClinicalTrialResults.xhtml